SecBot SecBot
DEFA14A ·Filed Apr 22, 2026

BVS

Bioventus Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001665988-26-000015
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the company's next 10-Q filing for any updates on financial performance or corporate strategy.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$9.77
T+0 close · Apr 22, 2026 · via day close
Latest settled
+23.44%
T+60 · $12.06
Vs SPY
+18.66%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 22 $9.77entry
  2. T+1 · 7mo ago −0.61%α −0.22% · $9.71
  3. T+5 · 7mo ago −0.31%α −0.36% · $9.74
  4. T+20 · 6mo ago +9.11%α +5.94% · $10.66
  5. T+60 · 4mo ago +23.44%α +18.66% · $12.06
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Bioventus Inc. has filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting. The filing is routine and does not contain any material financial information or significant corporate actions.

Key Facts

  • Bioventus Inc. has filed a definitive proxy statement (DEFA14A) with the SEC
  • The filing is a routine disclosure required by securities regulations
  • The document does not contain any material financial information or significant corporate actions
  • The filing is categorized as a definitive proxy statement

Financial Impact

No financial impact

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001665988-26-000015
Document: 0001665988-26-000015-index-headers.html0001665988-26-000015
Document: 0001665988-26-000015-index.html0001665988-26-000015
Document: 0001665988-26-000015.txt0001665988-26-000015

Track record

18 reports on BVS

Performance horizon

2 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +37.19% at T+60 after the May 8, 2026 report. 3 of 7 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $10.66 Now $10.46 −1.88% settles Feb 11
  2. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $10.61 Now $10.46 −1.41% settles Feb 4
  3. Nov 2, 202614d ago 8-K Neutral 5/10 No price data
  4. Nov 2, 202614d ago Press Release Neutral 5/10 Entry $10.95 Now $10.46 −4.43% settles Feb 1
  5. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $14.65 Now $10.46 −28.60% settles Jan 26
  6. Aug 15, 202613w ago Institutional Cluster Mixed 5/10 Entry $13.88 to $11.02 Now $10.46 −24.64% ▼ −20.64% −17.88% vs SPY
  7. Aug 5, 202614w ago 8-K Bullish 7/10 No price data
  8. Aug 5, 202614w ago Press Release Bullish 7/10 Entry $15.26 to $14.86 Now $10.46 −31.45% ▼ −2.62% −2.81% vs SPY
  9. Jun 11, 202622w ago Institutional Cluster Bearish 4/10 Entry $8.68 to $14.07 Now $10.46 −20.51% ▼ −62.10% −57.70% vs SPY
  10. Jun 2, 202623w ago Press Release Bearish 6/10 Entry $8.11 to $13.97 Now $10.46 −28.98% ▼ −72.26% −71.14% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens in 6h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 22, 2026